Loading...

HRP Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Horseradish Peroxidase, SAv-HRP
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
405210 1 mL 129 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-HRP is useful for detecting biotinylated antibodies, e.g., in ELISA, ELISPOT, IHC or Western blotting. For ELISA applications, HRP will act on soluble substrates, such as ABTS or TMB, to yield a colorimetric reaction. For ELISPOT or Western blotting applications, HRP will act on precipitating substrates, such as 4CN, to yield a colorimetric reaction.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human,Mouse,Rat,All Species
Formulation
Buffered solution containing bovine protein and preservatives (methylisothiazolone, bromonitrodioxane, and other active isothiazolones).
Preparation
Streptavidin is conjugated with horseradish peroxidase under optimal conditions.
Storage & Handling
The streptavidin-HRP solution should be stored undiluted between 2°C and 8°C. Avoid exposure to sodium azide.

To obtain lot-specific expiration date, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)

This product has a shelf-life of 12 months or less. Please use our Expiration Lookup Tool to verify the expiration date of your lot of product
Application

ELISA - Quality tested
ELISPOT, WB, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this Streptavidin-HRP is quality control tested by ELISA assay. For ELISA or Western blot analysis, the reagent should be titrated between 1:1000 - 1:3000 to determine optimal conditions. For ELISPOT analysis, the reagent should be titrated between 1:500 - 1:1500 to determine optimal conditions. Avoid using biotin-containing solutions as diluents and solutions containing sodium azide. Sodium azide is an inhibitor of horseradish peroxidase. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Streptavidin-HRP is useful as a second step reagent for indirect enzymatic labelling, in conjunction with biotinylated primary antibodies. Sav-HRP is recommended for ELISA, ELISPOT and Western blotting, when used with the relevant substrate system.

Application References

(PubMed link indicates BioLegend citation)
  1. Li KJ, et al. 2006. J. Leukoc. Biol. doi:10.1189/jlb.1105668.PubMed
  2. Weldon S, et al. 2009. J. Immunol. 183:8148. PubMed
  3. Basnayake K, et al. 2010. J Am Soc Naphrol. 21:1165. PubMed
  4. Marder W, et al. 2011. Ann Rheum Dis. PubMed
  5. Cheng J, et al. 2012. Mol Biol Cell. 23:2891. PubMed
  6. Vishwakarma V, et al. 2012. Infect Immun. 80:3236. PubMed
  7. Sun X, et al. 2013. J. Immunol. 190:2536. PubMed
  8. Van Phan T, et al. 2013. Biochem Pharmacol. 85:1145. PubMed
  9. Ranganathan P, et al. 2013. J Rhematol. 40:129. PubMed
  10. Din Su, et al. 2013. Occup Med. PubMed
  11. Bulut GB, et al. 2013. Blood. 122:3964. PubMed
  12. Chia YL, et al. 2013. Antiviral Res. 3542:354. PubMed
  13. Ahn JM, et al. 2014. Mol Cell Proteomics. 13:30. PubMed
  14. Din SU, et al. 2014. Occup Med. 64:39. PubMed
  15. Balmer ML, et al. 2014. Sci Transl Med. 21:237. PubMed
  16. Klehmet J, et al. 2014. J Neurol Neurosurg Psychiatry. PubMed
  17. Wu CC, et al. 2014. Cancer Epidemiol. Biomarkers Prev. 23:1569. PubMed
  18. Peng JG, et al. 2014. J Virol. 88:8386. PubMed
  19. Chlon TM, et al. 2014. J Virol. 88:11315. PubMed
  20. Sadovskaya I, et al. 2014. Carbohydr Poly. 111:139. PubMed
  21. Liu T, et al. 2015. Infect Immun. 83:2011. PubMed
  22. Himmelein S, et al. 2015. J Virol. 89:5747. PubMed
  23. Dinter J, et al. 2015. J Mol Endocrinol. 54:205. PubMed
  24. Yang L, et al. 2015. J Immunol. 194:5635. PubMed
Product Citations
  1. Kiriakidis S, et al. 2017. Kidney International. 10.1016/j.kint.2017.03.008. PubMed
  2. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  3. Hooper K, Kong W, Ganea D, et al. 2017. PLoS One. 12(6):e0179184. PubMed
  4. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  5. Gröschel C, et al. 2017. Sci Rep.. 10.1038/s41598-017-16147-1. PubMed
  6. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  7. Gröschel C, et al. 2018. Front Immunol. 9:2665. PubMed
  8. Wang YH, et al. 2018. Oncol Lett. 16:6903. PubMed
  9. Cárdenas–Torres FI, et al. 2019. Medicina (Kaunas). 55:3. PubMed
  10. Simic MS, et al. 2019. Sci Adv. 5:eaaw0025. PubMed
  11. Kikuchi N, et al. 2019. Biol Pharm Bull. 42:57. PubMed
  12. Gamache J, et al. 2019. Nat Commun. 10:2479. PubMed
  13. Duan S, et al. 2019. J Clin Invest. 129:1387. PubMed
  14. Nakanishi M, et al. 2019. Cell. 177:910. PubMed
  15. Crowley SJ, et al. 2020. Open Biol. 10:190235. PubMed
  16. Tuladhar R, et al. 2019. J Biol Chem. 294:6273. PubMed
  17. Herp S, et al. 2019. Cell Host Microbe. 25:681. PubMed
  18. den Hartigh AB, et al. 2018. Curr Protoc Immunol. :e52. PubMed
  19. Li K, et al. 2006. J Leukoc Biol . 80:350. PubMed
  20. Weldon S, et al. 2009. J Immunol. 183:8148. PubMed
  21. Basnayake K, et al. 2010. J Am Soc Nephrol. 1.684027778. PubMed
  22. Marder W, et al. 2011. Ann Rheum Dis. 70:1550. PubMed
  23. Cheng J, et al. 2012. Mol Biol Cell. 23:2891. PubMed
  24. Vishwakarma V, et al. 2012. Infect Immun . 80:3236. PubMed
  25. Sun X, et al. 2013. J Immunol. 190:2536. PubMed
  26. Phan T, et al. 2013. Biochem Pharmacol. 85:1145. PubMed
  27. Bulut G, et al. 2013. Blood. 122:3964. PubMed
  28. Chia Y, et al. 2013. Antiviral Res. 3542:354. PubMed
  29. Ahn J, et al. 2014. Mol Cell Proteomics. 13:30. PubMed
  30. Tidley S 2014. Occup Med. 64:39. PubMed
  31. Balmer M, et al. 2014. Sci Transl Med. 21:237. PubMed
  32. Klehmet J, et al. 2014. J Neurol Psychiatry. . PubMed
  33. Wu C, et al. 2014. Cancer Epidemiol Biomarkers Prev. 23:1569. PubMed
  34. Wu J 2014. J Virol. 88:8386. PubMed
  35. Chlon T, et al. 2014. J Virol. 88:11315. PubMed
  36. Sadovskaya I, et al. 2014. Carbohydr Polym. 111:139. PubMed
  37. Liu T, et al. 2015. Infect Immun . 83:2011. PubMed
  38. Himmelein S, et al. 2015. J Virol. 89:5747. PubMed
  39. Dinter J, et al. 2015. J Mol Endocrinol. 54:205. PubMed
  40. Shinohara M 2015. J Immunol. 194:5635. PubMed
  41. Zhang C, et al. 2015. J Surgical Res. 197: 301-306. PubMed
  42. Isernhagen A, et al. 2015. EMBO Mol Med. 7: 1480 - 1502. PubMed
  43. Hwang D, et al. 2016. PLoS One. 11: 0152522. PubMed
  44. Baerenwaldt A, et al. 2016. J Immunol. 196: 2561 - 2571. PubMed
  45. Parrish H, et al. 2016. Proc Natl Acad Sci U S A. 113: 3000 - 3005. PubMed
  46. Yen J, et al. 2015. J Leukoc Biol. 98: 689-702. PubMed
  47. Tu S, et al. 2015. Nature. 534:387-390. PubMed
  48. Czakai K, et al. 2016. Sci Rep. 6:27990. PubMed
  49. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  50. Brugiroux S, et al. 2016. Nat Microbiol. 2:16215. PubMed
  51. Ye F, et al. 2016. J Virol. 90: 9654 - 9663. PubMed
  52. MÜller A, et al. 2016. PLoS One. 11:e0168260. PubMed
  53. Tsanov K, et al. 2016. Nat Cell Biol. 19:60-67. PubMed
  54. Gendron D, et al. 2017. Pulm Pharmacol Ther. 10.1016/j.pupt.2017.03.010. PubMed
  55. Counoupas C, et al. 2020. NPJ Vaccines. 0.28125. PubMed
  56. Xing QR, et al. 2020. Sci Adv. 6:00. PubMed
  57. Kim DJ, et al. 2020. Proc Natl Acad Sci U S A. 117:15837. PubMed
  58. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  59. Li Q, et al. 2020. Cell Stem Cell. 675:26. PubMed
  60. Sinha D, et al. 2020. Anal Biochem. 113827:608. PubMed
  61. von Wenserski L, et al. 2020. Leukemia. . PubMed
  62. Watanabe T, et al. 2020. Cytotherapy. . PubMed
  63. Asarnow D, et al. 2021. Cell. 184:3192. PubMed
  64. Ozawa T, et al. 2021. iScience. 24:102488. PubMed
  65. Clemente V, et al. 2021. Cells. 10: . PubMed
  66. Ugurlu-Çimen D, et al. 2021. Epigenetics Chromatin. 14:32. PubMed
  67. Makowski EK, et al. 2021. MAbs. 13:1951426. PubMed
  68. Fan X, et al. 2021. Int J Mol Sci. 22:. PubMed
  69. Phillips AT, et al. 2021. Invest Ophthalmol Vis Sci. 62:15. PubMed
  70. Vijver SV, et al. 2021. Front Immunol. 12:733561. PubMed
  71. Sielemann J, et al. 2021. Nat Commun. 12:6549. PubMed
  72. Csobán-Szabó Z, et al. 2021. Int J Mol Sci. 22:. PubMed
  73. Lopez-Gordo E, et al. 2022. Front Med (Lausanne). 8:732095. PubMed
  74. Tabynov K, et al. 2022. NPJ Vaccines. 7:24. PubMed
  75. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  76. Cildag S, et al. 2021. Med Pharm Rep. 94:53. PubMed
  77. Morita M, et al. 2021. Heliyon. 7:e06228. PubMed
  78. Duan S, et al. 2021. J Immunol. 206:2290. PubMed
  79. Shukla SP, et al. 2021. Int J Mol Sci. 22:. PubMed
  80. Clemente V, et al. 2022. Cancer Res Commun. 2:784. PubMed
  81. Bello A, et al. 2021. Immunol Cell Biol. 99:879. PubMed
  82. Kongsuphol P, et al. 2022. Commun Med (Lond). 1:46. PubMed
  83. Laver JR, et al. 2021. Sci Transl Med. 13: . PubMed
  84. Wang Q, et al. 2022. EMBO J. 41:e110636. PubMed
  85. Johnson BS, et al. 2022. Mol Cell Proteomics. 21:100256. PubMed
  86. Ye D, et al. 2022. J Pineal Res. 73:e12828. PubMed
  87. Gao SS, et al. 2022. iScience. 25:105481. PubMed
  88. He Q, et al. 2023. Life Sci Alliance. 6: . PubMed
  89. Cho YK, et al. 2022. Sci Adv. 8:eabq4022. PubMed
  90. Qin J, et al. 2023. Front Immunol. 14:1126392. PubMed
Go To Top Version: 6    Revision Date: 12.12.2022

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account